Clinical Trial Update: Effect of N-acetylcystein in Myocardial Infarction [Phase 3]

View source ↗

Summary

This document provides a Phase 3 clinical trial update on N-acetylcysteine for acute myocardial infarction, with the current trial status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Acute Myocardial Infarction | Phase 3 | Status: UNKNOWN